Literature DB >> 19066725

Synthesis of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives as antiproliferative agents: a structure-activity relationship study.

S B Benaka Prasad1, K Vinaya, C S Ananda Kumar, Sanjay Swarup, K S Rangappa.   

Abstract

A series of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives 5(a-m) were synthesized with different substituted aromatic/heterocyclic acid chlorides (R-CO-Cl) and characterized by (1)H NMR, LC/MS, FTIR and elemental analyses. All the compounds synthesised were evaluated for their antiproliferative activity by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The antiproliferative effects of the synthesised compounds were tested against viable human skin fibroblast cells and carcinoma cells namely HeLa cells, HT-29 cells, MCF-7 cells, HepG-2 cells by adopting positive and negative control. The importance of the aromatic and heterocyclic moiety was confirmed. From the SAR studies, it reveals that, the substitution at N-terminal of 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole by the heterocyclic ring plays a dominant role and was responsible for the antiproliferative activity. Among the synthesized compounds 5a, 5d and 5k have showed potent antiproliferative activity on all the carcinoma cells tested.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066725     DOI: 10.1007/s10637-008-9205-5

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  16 in total

Review 1.  Discovering novel chemotherapeutic drugs for the third millennium.

Authors:  M D Garrett; P Workman
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

2.  Potential antiinflammatory compounds. 2. Acidic antiinflammatory 1,2-benzisoxazoles.

Authors:  J C Saunders; W R Williamson
Journal:  J Med Chem       Date:  1979-12       Impact factor: 7.446

3.  Synthesis and evaluation of 6-[11C]methoxy-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-1,2- benzisoxazole as an in vivo radioligand for acetylcholinesterase.

Authors:  C Brown-Proctor; S E Snyder; P S Sherman; M R Kilbourn
Journal:  Nucl Med Biol       Date:  1999-01       Impact factor: 2.408

Review 4.  Effects of fluorine substitution on drug metabolism: pharmacological and toxicological implications.

Authors:  B K Park; N R Kitteringham
Journal:  Drug Metab Rev       Date:  1994       Impact factor: 4.518

5.  Incidence and prevalence of all cancerous diseases in Italy: trends and implications.

Authors:  A Verdecchia; A Mariotto; R Capocaccia; G Gatta; A Micheli; M Sant; F Berrino
Journal:  Eur J Cancer       Date:  2001-06       Impact factor: 9.162

6.  Reductive metabolism of the anticonvulsant agent zonisamide, a 1,2-benzisoxazole derivative.

Authors:  D D Stiff; J T Robicheau; M A Zemaitis
Journal:  Xenobiotica       Date:  1992-01       Impact factor: 1.908

7.  Pilot clinical investigation of risperidone in the treatment of psychotic patients.

Authors:  Y G Gelders; S L Heylen; G Vanden Bussche; A J Reyntjens; P A Janssen
Journal:  Pharmacopsychiatry       Date:  1990-09       Impact factor: 5.788

8.  Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure-activity relationship study.

Authors:  C S Ananda Kumar; S B Benaka Prasad; K Vinaya; S Chandrappa; N R Thimmegowda; S R Ranganatha; Sanjay Swarup; K S Rangappa
Journal:  Invest New Drugs       Date:  2008-07-08       Impact factor: 3.850

9.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

Authors:  D A Scudiero; R H Shoemaker; K D Paull; A Monks; S Tierney; T H Nofziger; M J Currens; D Seniff; M R Boyd
Journal:  Cancer Res       Date:  1988-09-01       Impact factor: 12.701

10.  1,2-benzisoxazole phosphorodiamidates as novel anticancer prodrugs requiring bioreductive activation.

Authors:  Monish Jain; Chul-Hoon Kwon
Journal:  J Med Chem       Date:  2003-12-04       Impact factor: 7.446

View more
  2 in total

1.  Solution-phase synthesis of a diverse library of benzisoxazoles utilizing the [3 + 2] cycloaddition of in situ-generated nitrile oxides and arynes.

Authors:  Anton V Dubrovskiy; Prashi Jain; Feng Shi; Gerald H Lushington; Conrad Santini; Patrick Porubsky; Richard C Larock
Journal:  ACS Comb Sci       Date:  2013-03-08       Impact factor: 3.784

Review 2.  Benzisoxazole: a privileged scaffold for medicinal chemistry.

Authors:  K P Rakesh; C S Shantharam; M B Sridhara; H M Manukumar; Hua-Li Qin
Journal:  Medchemcomm       Date:  2017-10-31       Impact factor: 3.597

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.